The Southern African Journal of Anaesthesia and Analgesia (SAJAA) is the official journal of the South African Society of Anaesthesiologists (SASA). The SAJAA is distributed to the most influential role players and decision makers in this therapeutic field. Anaesthesiologists rely on the SAJAA to provide them with review articles, case studies and original research, written by key opinion leaders, on a wide range of topics that affect their daily clinical practice. The SAJAA is utilised by SASA to publish and update national guidelines, and is the official publication of the annual SASA congress.

SAJAA (January – June 2017) | 2 202

CIPLA LAUNCHES NEW TRIPLE-COMBINATION ANTIRETROVIRAL DRUG, REYDIN

Ahead of World Aids Day and as part of its continued commitment to ensuring access to quality, affordable antiretrovirals (ARV), Cipla is launching its new triple-combination ARV treatment for HIV in South Africa.

Empagliflozin proven to improve clinical outcomes in real world practice across a broad spectrum of cardiovascular risk

The most recent 2018 treatment recommendations from the American Diabetes Association are that, after considering drug specific and patient factors, treatment for people with atherosclerotic cardiovascular disease (ASCVD) should begin with lifestyle management and metformin and subsequently incorporate an agent proven to reduce major adverse cardiovascular events and/or cardiovascular mortality.

Skin protection range, Dexeryl, receives Allergy Foundation’s seal of approval

Partnership brings established international brand to South African consumers with complementary barrier and cleansing presentations for dry skins.

EXPERTS CALL FOR NATIONWIDE ADOPTION OF BUGWISE APP AMONG GPs TO KEEP ANTIBIOTIC RESISTANCE IN CHECK

Amid increased reporting of antibiotic resistance (ABR) worldwide, local health experts have called on South African doctors to more fully participate in and support efforts aimed at curbing the growing threat of antibiotic resistant superbugs in our country.

New Novartis South Africa CEO to continue building on partnerships

Novartis South Africa aims to continue building on local partnerships and health development initiatives, following the appointment of Dr. Mahomed (Mo) Kadwa as the company’s new Chief Executive Officer: Novartis South Africa and Head: Southern African Countries.

Wildcard SSL